• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细菌诱变性数据评估的推荐标准(艾姆斯试验)。

Recommended criteria for the evaluation of bacterial mutagenicity data (Ames test).

作者信息

Levy Dan D, Zeiger Errol, Escobar Patricia A, Hakura Atsushi, van der Leede Bas-Jan M, Kato Masayuki, Moore Martha M, Sugiyama Kei-Ichi

机构信息

US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, 20740, USA.

Errol Zeiger Consulting, Chapel Hill, NC, 27514, USA.

出版信息

Mutat Res Genet Toxicol Environ Mutagen. 2019 Dec;848:403074. doi: 10.1016/j.mrgentox.2019.07.004. Epub 2019 Aug 5.

DOI:10.1016/j.mrgentox.2019.07.004
PMID:31708073
Abstract

A committee was constituted within the International Workshop on Genetic Toxicology Testing (IWGT) to evaluate the current criteria for a valid Ames test and to provide recommendations for interpretation of test results. Currently, determination of a positive vs. a negative result is made by applying various data evaluation procedures for comparing dosed plates with the concurrent solvent control plates. These evaluation procedures include a requirement for a specific fold increase (2- or 3-fold, specific to the bacterial strain), formal statistical procedures, or subjective (expert judgment) evaluation. After extensive discussion, the workgroup was not able to reach consensus recommendations in favor of any of these procedures. There was a consensus that combining additional evaluation criteria to the comparison between dosed plates and the concurrent solvent control plates improves test interpretation. The workgroup recommended using these additional criteria because the induction of mutations is a continuum of responses and there is no biological relevance to a strict dividing line between a positive (mutagenic) and not-positive (nonmutagenic) response. The most useful additional criteria identified were a concentration-response relationship and consideration of a possible increase above the concurrent control in the context of the laboratory's historical solvent control values for the particular tester strain. The workgroup also emphasized the need for additional testing to resolve weak or inconclusive responses, usually with altered experimental conditions chosen based on the initial results. Use of these multiple criteria allowed the workgroup to reach consensus on definitions of "clear positive" and "clear negative" responses which would not require a repeat test for clarification. The workgroup also reached consensus on recommendations to compare the responses of concurrent positive and negative controls to historical control distributions for assay acceptability, and the use of control charts to determine the validity of the individual test.

摘要

国际遗传毒理学测试研讨会(IWGT)成立了一个委员会,以评估现行有效的艾姆斯试验标准,并就试验结果的解释提供建议。目前,通过应用各种数据评估程序来比较加药平板与同时进行的溶剂对照平板,从而确定阳性与阴性结果。这些评估程序包括要求特定的倍数增加(2倍或3倍,具体取决于细菌菌株)、正式的统计程序或主观(专家判断)评估。经过广泛讨论,工作组未能就支持这些程序中的任何一种达成共识性建议。大家一致认为,在加药平板与同时进行的溶剂对照平板的比较中加入额外的评估标准,可改善试验解释。工作组建议使用这些额外标准,因为突变的诱导是一个连续的反应过程,阳性(致突变)和非阳性(非致突变)反应之间的严格分界线没有生物学意义。确定的最有用的额外标准是浓度-反应关系,以及在特定测试菌株的实验室历史溶剂对照值的背景下,考虑相对于同时对照可能的增加。工作组还强调需要进行额外测试,以解决微弱或不确定的反应,通常是根据初始结果选择改变实验条件。使用这些多重标准使工作组能够就“明确阳性”和“明确阴性”反应的定义达成共识,这无需重复测试来澄清。工作组还就比较同时进行的阳性和阴性对照的反应与历史对照分布以确定试验可接受性的建议,以及使用控制图来确定单个测试的有效性达成了共识。

相似文献

1
Recommended criteria for the evaluation of bacterial mutagenicity data (Ames test).细菌诱变性数据评估的推荐标准(艾姆斯试验)。
Mutat Res Genet Toxicol Environ Mutagen. 2019 Dec;848:403074. doi: 10.1016/j.mrgentox.2019.07.004. Epub 2019 Aug 5.
2
Revisiting the bacterial mutagenicity assays: Report by a workgroup of the International Workshops on Genotoxicity Testing (IWGT).重新审视细菌致突变性试验:遗传毒性测试国际研讨会(IWGT)一个工作组的报告
Mutat Res Genet Toxicol Environ Mutagen. 2020 Jan;849:503137. doi: 10.1016/j.mrgentox.2020.503137. Epub 2020 Jan 13.
3
Determination of a positive response in the Ames Salmonella mutagenicity assay.Ames 沙门氏菌致突变性检测中阳性反应的判定。
Environ Mol Mutagen. 2023 Apr;64(4):250-258. doi: 10.1002/em.22538. Epub 2023 Mar 31.
4
Assessing the quality and making appropriate use of historical negative control data: A report of the International Workshop on Genotoxicity Testing (IWGT).评估历史阴性对照数据的质量并合理使用:遗传毒性测试国际研讨会(IWGT)报告
Environ Mol Mutagen. 2023 Apr 25. doi: 10.1002/em.22541.
5
Recommendations for the performance of bacterial mutation assays.细菌突变试验的操作建议。
Mutat Res. 1994 Jun;312(3):217-33. doi: 10.1016/0165-1161(94)90037-x.
6
Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.遗传毒性测试策略:与体外测试相关的危害识别和风险评估
Mutat Res. 2007 Feb 3;627(1):41-58. doi: 10.1016/j.mrgentox.2006.10.003. Epub 2006 Nov 27.
7
Mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the International Workshop on Genotoxicity Testing--Aberdeen, Scotland, 2003--Assay acceptance criteria, positive controls, and data evaluation.小鼠淋巴瘤胸苷激酶基因突变试验:遗传毒性检测国际研讨会后续会议——2003年,苏格兰阿伯丁——试验验收标准、阳性对照及数据评估
Environ Mol Mutagen. 2006 Jan;47(1):1-5. doi: 10.1002/em.20159.
8
Validation of the Salmonella (SV50)/arabinose-resistant forward mutation assay system with 26 compounds.用26种化合物对沙门氏菌(SV50)/抗阿拉伯糖正向突变检测系统进行验证。
Mutat Res. 1984 Apr;130(2):79-86. doi: 10.1016/0165-1161(84)90107-9.
9
A comparison of 24 chemicals in the six-well bacterial reverse mutation assay to the standard 100-mm Petri plate bacterial reverse mutation assay in two laboratories.在两个实验室中,对六孔细菌回复突变试验中的 24 种化学物质与标准的 100mm 培养皿细菌回复突变试验进行比较。
Regul Toxicol Pharmacol. 2018 Dec;100:134-160. doi: 10.1016/j.yrtph.2018.10.005. Epub 2018 Oct 26.
10
Mutagenicity evaluation of pesticide analogs using standard and 6-well miniaturized bacterial reverse mutation tests.采用标准和 6 孔微型细菌回复突变试验对农药类似物进行致突变性评价。
Toxicol In Vitro. 2020 Dec;69:105006. doi: 10.1016/j.tiv.2020.105006. Epub 2020 Sep 23.

引用本文的文献

1
Structure-mutagenicity relationships on quinoline and indole analogues in the Ames test.艾姆斯试验中喹啉和吲哚类似物的结构-致突变性关系。
Genes Environ. 2024 Nov 14;46(1):23. doi: 10.1186/s41021-024-00316-6.
2
Structure confirmation, reactivity, bacterial mutagenicity and quantification of 2,2,4-tribromo-5-hydroxycyclopent-4-ene-1,3-dione in drinking water.饮用水中2,2,4-三溴-5-羟基环戊-4-烯-1,3-二酮的结构确认、反应活性、细菌致突变性及定量分析
Commun Chem. 2024 Nov 14;7(1):266. doi: 10.1038/s42004-024-01356-3.
3
Prediction Intervals for Overdispersed Poisson Data and Their Application in Medical and Pre-Clinical Quality Control.
过度分散泊松数据的预测区间及其在医学和临床前质量控制中的应用。
Pharm Stat. 2025 Mar-Apr;24(2):e2447. doi: 10.1002/pst.2447. Epub 2024 Oct 30.
4
Design and synthesis of novel 2-(2-(4-bromophenyl)quinolin-4-yl)-1,3,4-oxadiazole derivatives as anticancer and antimicrobial candidates: and studies.新型2-(2-(4-溴苯基)喹啉-4-基)-1,3,4-恶二唑衍生物作为抗癌和抗菌候选物的设计与合成及研究
RSC Adv. 2024 Oct 25;14(46):34005-34026. doi: 10.1039/d4ra06712f. eCollection 2024 Oct 23.
5
Optimizing the detection of N-nitrosamine mutagenicity in the Ames test.优化 Ames 试验中 N-亚硝胺致突变性的检测。
Regul Toxicol Pharmacol. 2024 Nov;153:105709. doi: 10.1016/j.yrtph.2024.105709. Epub 2024 Sep 28.
6
Industrial ecotoxicology in focus: The unexplored environmental impacts of pilot-scale advanced filtration in Sc recovery.聚焦工业生态毒理学:中试规模先进过滤回收钪过程中未被探索的环境影响。
Heliyon. 2024 Jun 28;10(13):e33799. doi: 10.1016/j.heliyon.2024.e33799. eCollection 2024 Jul 15.
7
Toxicity Evaluation of a Non-Pain Pharmacopuncture Extract Using a Bacterial Reverse Mutation Test.使用细菌回复突变试验对一种非止痛药物针灸提取物进行毒性评估。
J Pharmacopuncture. 2024 Jun 30;27(2):154-161. doi: 10.3831/KPI.2024.27.2.154.
8
Repurposed organoselenium tethered amidic acids as apoptosis inducers in melanoma cancer P53, BAX, caspases-3, 6, 8, 9, BCL-2, MMP2, and MMP9 modulations.重新利用的有机硒连接酰胺酸作为黑色素瘤癌症中的凋亡诱导剂:P53、BAX、半胱天冬酶-3、6、8、9、BCL-2、基质金属蛋白酶2和基质金属蛋白酶9的调节。
RSC Adv. 2024 Jun 10;14(26):18576-18587. doi: 10.1039/d4ra02944e. eCollection 2024 Jun 6.
9
Advancing Drug Safety in Drug Development: Bridging Computational Predictions for Enhanced Toxicity Prediction.推进药物研发中的药物安全性:弥合计算预测差距,提高毒性预测能力。
Chem Res Toxicol. 2024 Jun 17;37(6):827-849. doi: 10.1021/acs.chemrestox.3c00352. Epub 2024 May 17.
10
Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment.利用分子杂交方法发现新型喹啉类表皮生长因子受体酪氨酸激酶抑制剂用于癌症治疗。
Future Med Chem. 2024;16(11):1087-1107. doi: 10.1080/17568919.2024.2342201. Epub 2024 May 9.